You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rho(D) Immune Globulin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Trial in United States (Eltrombopag, Steroids, IVIG)

Recruiting
  • Immune Thrombocytopenia
  • Birmingham, Alabama
  • +26 more
Dec 12, 2022

Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia Trial in Finland, Sweden (Immune Globulin

Completed
  • Primary Immunodeficiency Diseases (PID)
  • +2 more
  • Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
  • Gammagard S/D (Solvent/Detergent)
  • Tampere, Finland
  • +5 more
Aug 22, 2021

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Post-polio Syndrome Trial in Worldwide (Flebogamma 5% DIF, Placebo)

Suspended
  • Post-polio Syndrome
  • Flebogamma 5% DIF
  • Placebo
  • Saint Louis, Missouri
  • +26 more
Jan 27, 2022

Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

Recruiting
  • Lung Transplant
  • Hepatitis B
  • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Hospital of University of Pennsylvania
Oct 1, 2022

Sickle Cell Disease, Pain Trial in Bronx (Immune Globulin Intravenous, Normal saline)

Recruiting
  • Sickle Cell Disease
  • Pain
  • Immune Globulin Intravenous
  • Normal saline
  • Bronx, New York
    Montefiore Medical Center
Jul 25, 2022

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022

Survey of Human Rabies Immune Globulin Safety in Children

Recruiting
  • Rabies
  • +3 more
  • Human rabies immune globulin 300 IU/mL
  • Houston, Texas
    Houston Methodist
Aug 22, 2022

COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)

Not yet recruiting
  • COPD Exacerbation Acute
  • CUVITRU - Ig subcutaneous human 20%
  • Standard Medical Therapy
  • Rochester, New York
  • +2 more
Feb 28, 2023

Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)

Completed
Has Results
  • Immunologic Deficiency Syndromes
  • GC5107
  • Centennial, Colorado
  • +19 more
Nov 11, 2022

HFRS (Hemorrhagic Fever With Renal Syndrome) Trial in China (IVIG 20g/d, IVIG 10g/d)

Recruiting
  • HFRS (Hemorrhagic Fever With Renal Syndrome)
  • IVIG 20g/d
  • IVIG 10g/d
  • Guangshui, Hu Bei Province, China
  • +8 more
Aug 22, 2023

Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

Withdrawn
  • Chronic Hepatitis B
  • hepatitis B immune globulin (HBIg)
  • Pegylated interferon alfa (pegIFN)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 4, 2022

Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))

Withdrawn
  • Healthy
  • Communicable Diseases
  • Vaccinia Immune Globulin (Human)
  • (no location specified)
Oct 28, 2021

Guillain-Barre Syndrome Trial in Wenzhou (Intravenous Immunoglobulins, Human, Methylprednisolone 500 MG Injection)

Recruiting
  • Guillain-Barre Syndrome
  • Intravenous Immunoglobulins, Human
  • Methylprednisolone 500 MG Injection
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023

Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP), Kawasaki Syndrome Trial in United States (Immune

Completed
  • Primary Immunodeficiency Diseases (PID)
  • +2 more
  • Immune Globulin Intravenous (Human), 10%
  • Los Angeles, California
  • +10 more
Aug 22, 2021

Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)

Recruiting
  • Obesity
  • Immune Deficiency
  • Institutional standard intravenous immune globulin treatment
  • Somerville, New Jersey
    Robert Wood Johnson University Hospital Somerset
Oct 10, 2022

Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)

Recruiting
  • Severe Fever With Thrombocytopenia Syndrome
  • Guangshui, Hubei, China
  • +9 more
Oct 31, 2022

COVID-19 Trial in Spain (Intravenous Immune Globulin, Standard Medical Treatment)

Completed
  • COVID-19
  • Intravenous Immune Globulin
  • Standard Medical Treatment
  • San Sebastián De Los Reyes, Madrid, Spain
  • +9 more
Mar 9, 2021

Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)

Completed
  • Renal Transplant
  • Seoul, Korea, Republic of
  • +1 more
Oct 25, 2022

Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Australia, Canada,

Completed
Has Results
  • Localized Resectable Neuroblastoma
  • +4 more
  • Clinical Observation
  • +5 more
  • Birmingham, Alabama
  • +103 more
Jan 4, 2023

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%

Completed
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Intravenous (IGIV)
  • Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
  • Nagoya-shi, Aichi, Japan
  • +7 more
Feb 23, 2022